Standout Papers

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for... 2011 2026 2016 2021 523
  1. Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer (2011)
    Daniel G. Haller, Josep Tabernero et al. Journal of Clinical Oncology
  2. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial (2019)
    Toby M. Maher, Tamera J. Corte et al. The Lancet Respiratory Medicine

Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 20

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
2 intermediate papers

Works of Frank Gilberg being referenced

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
2018
Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial
2017

Author Peers

Author Last Decade Papers Cites
Frank Gilberg 1033 1160 270 407 34 2.2k
A. Morganti 1596 500 313 392 22 2.4k
James B. Gerstner 533 1538 169 415 29 2.1k
R. G. Hahn 636 1140 107 259 45 1.9k
J. Philip Kuebler 708 1702 81 251 38 2.1k
T Ishikawa 579 1482 138 130 33 2.2k
Robert W. Talley 715 1137 43 692 50 2.3k
William K. Murphy 1286 1951 115 188 73 2.9k
Howard M. Gross 527 1373 113 441 55 2.5k
Florian Eckel 644 996 92 135 49 1.9k
A. Norman 794 999 476 233 42 2.2k

All Works

Loading papers...

Rankless by CCL
2026